Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Managed care DUR required in Kennedy/Dingell bill; Medicare cancer trial coverage bill introduced.

Executive Summary

DUR REQUIREMENT INCLUDED IN KENNEDY/DINGELL MANAGED CARE BILL as part of the "Health Insurance Bill of Rights" introduced Feb. 25. The "Quality Assurance and Patient Protection Act" (S 353/HR 820) introduced by Senate Labor Committee ranking Democrat Kennedy (D-Mass.) and House Commerce Committee ranking Democrat Dingell (D-Mich.) requires that any managed care plan that "covers prescription medications...must have a plan to encourage appropriate drug use and monitor and reduce illness arising from improper use."

Latest Headlines
See All
UsernamePublicRestriction

Register

PS029810

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel